Literature DB >> 6332987

Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones.

B Toyonaga, Y Yanagi, N Suciu-Foca, M Minden, T W Mak.   

Abstract

An essential property of the immune response is its ability to distinguish between self and non-self and to generate enormous diversity in antibody and T-cell immune responses. Although the genetic and molecular mechanisms responsible for antibody diversity have now largely been elucidated, the structure of the T-cell receptor and the diversification of the receptor repertoire have only recently become amenable to study. One approach has involved immunochemical studies of the protein precipitated by monoclonal antibodies which react specifically with the immunizing T-cell clones. Another approach has been to clone and sequence a human or a murine T-cell specific message that may specify part of the T-cell receptor. We present here results of Southern blot analysis of non-T, immature T, and mature T-cell genomic DNA, and provide evidence that rearrangements of the YT35 sequences do occur in the DNA of thymic leukaemia T cells. This suggests that YT35 codes for at least part of the T-cell receptor and that rearrangements occur at this early stage of thymic ontogeny. Furthermore, DNA rearrangements are present in lymphocytes with phenotypic and functional characteristics of helper, killer, or suppressor T cells. We conclude that the three subpopulations of T cells operate via receptor molecules encoded by the same gene family.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332987     DOI: 10.1038/311385a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  31 in total

1.  Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies.

Authors:  M P Link; S J Stewart; R A Warnke; R Levy
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 2.  T lymphocytes in synovia of patients with rheumatoid arthritis.

Authors:  I Stamenkovic; M Stegagno; S M Krane; J T Kurnick
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Clonal dominance among T-lymphocyte infiltrates in arthritis.

Authors:  I Stamenkovic; M Stegagno; K A Wright; S M Krane; E P Amento; R B Colvin; R J Duquesnoy; J T Kurnick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Sequences and diversity of human T cell receptor beta chain variable region genes.

Authors:  N Kimura; B Toyonaga; Y Yoshikai; F Triebel; P Debre; M D Minden; T W Mak
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

5.  Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain.

Authors:  B Toyonaga; Y Yoshikai; V Vadasz; B Chin; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.

Authors:  N T O'Connor; J A Crick; J S Wainscoat; K C Gatter; H Stein; B Falini; D Y Mason
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

7.  Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line.

Authors:  Y Yanagi; A Chan; B Chin; M Minden; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 8.  The T cell antigen receptor.

Authors:  M K Collins; M J Owen
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

Review 9.  An appraisal of the application of recombinant DNA techniques to chromosome defects.

Authors:  K P Ellis; K E Davies
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

10.  Somatic rearrangement of T-cell antigen receptor gene in human T-cell malignancies.

Authors:  M D Minden; B Toyonaga; K Ha; Y Yanagi; B Chin; E Gelfand; T Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.